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Proteins of Toxoplasma gondii were separated by SDS-~lyac~iam~de gel electrophoresis with sub- 
sequent transfer to a nitrocellulose sheet by electrophoretic blotting. Immunologically ieactive polypep- 
tides were detected by human sera with previously known toxoplasma antibady levels. Heavy chain- 
specific, peroxidase-canjugated anti-human immunoglobulins were used as the indicator antibodies for the 
separate identification of IgG and IgM reactive polypeptides. IgG toxoplasma antibodies reacted with 
several antigens of && -~~~-~~~, while tox5plasma-speci~c IgM seemed to detect only a few 
poI~ept~des_ The iw, of 35ooO for the donating IgM reactive polypeptide was observed. 
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1. INTR~~U~TIUN by 
Toxoplasmosis, caused by the protozoan 
parasite Toxopiasma gondii, is a common infec- 
tion in humans with a world-wide distribution. 
Most infections are subclinical, or run a mild 
clinical course but in some cases severe manifesta- 
tions may be seen; especially in immunocom- 
promised patients and in congenital infections. 
specific antisera, immu~ol~~~ally reactive 
polypeptides separated and immobilized on the 
nitrocellulose replica. 
A strong humoral-immune response is usualIy 
evoked by the toxoplasma infection. The 
demonstration of specific antibody response con- 
stitutes the basis for the diagnosis of toxoplasmosis 
and several serological methods are available. 
However, very little is known about the antigenic 
structure of this parasite. 
We have applied a modification of this im- 
mu~oblotting technique for the demonstration of 
different antigenic com~nents of T. gon& as 
revealed by IgG and IgM toxoplasma antibodies 
from human sera. Our results suggest that the pat- 
terns of antigens eliciting IgG and IgM antibody 
responses against Toxoplasma are strikingly 
different. 
2. MATERIALS AND METHODS 
2.1. Preparation of Toxoplasma &sate 
Polyacryl~mide gel electrophoresis is a valuable 
tool for analysing complex protein mixtures 
because of its high resolution capacity. The pro- 
cedure for the transfer of proteins from a 
polyacrylamide gel to a nitrocellulose sheet as 
described in [I] has created possibilities to identify, 
Toxoplasma lysate for the sodium dodecyl 
sulfate-poIya~ryl~~de gel electrophoresis 
(SDS-PAGE) was prepared as follows. Tox- 
oplasma trophozoites were obtained from the 
peritoneal exudates af mice infected 4 days earlier 
with the RH strain af Toxoplasma gandii by in- 
traperitoneal inoculation. Contaminating mouse 
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cells were removed by differential centrifugation at 
300 rev./min for 10 min followed by 3 washes with 
0.9% NaCl solution. The pellet was resuspended in 
distilled water and sonicated. The lysate was stored 
in 100~1 aliquots at -70°C. 
2.2. Determination of toxoplasma antibodies 
Commercial Toxo-EIA-Kits for the determina- 
tion of IgG and IgM toxoplasma antibodies were 
used (Labsystems, Helsinki). The antibody levels 
of the serum samples are expressed as relative units 
(EIA units; EIU) derived from known positive 
references. The World Health Organization anti- 
toxoplasma reference serum (1000 IU/ml) con- 
tains 170 EIU of IgG toxoplasma antibodies. 
2.3. Human sera 
Five serum samples from different persons were 
used. All these sera had originally been submitted 
for the routine testing of IgG and IgM toxoplasma 
antibodies, after which the samples had been 
stored at - 20°C. Two of these sera, coded S-l and 
S-2, were from patients with clinically acute tox- 
oplasmosis verified by a lymph node biopsy. The 
3 other sera, coded S-3, S-4 and S-5, had been col- 
lected from laboratory personnel for screening 
purposes and all of them had been apparently 
healthy at the time of blood collection. The tox- 
oplasma antibody levels were 150 EIU for IgG and 
110 EIU for IgM in S-l; 130 EIU for IgG and 
90 EIU for IgM in S-2. The antibody levels for IgG 
in S-3 and S-4 were 100 EIU and 80 EIU, respec- 
tively; both samples were negative for IgM an- 
tibodies. S-5 was negative for both IgG and IgM 
toxoplasma antibodies and was used as a negative 
control serum. 
2.4. Polyacrylamide gel electrophoresis and the 
immunoblotting technique 
Toxoplasma lysate was exposed to a 
SDS-PAGE performed as in [2]. The lysate (1 mg 
protein/ml) was mixed in a 1: 2 ratio with the sam- 
ple buffer (0.02 M Tris-HCl (pH 6.8), 20% 
glycerol, 2% sodium dodecyl sulphate, 2% 
2-mercaptoethanol, 0.05% bromophenolblue) and 
boiled for 3 min in a water bath. Disrupted sample 
preparations (30 ,ul/track) were separated on a ver- 
tical 8% slab gel by electrophoresis at a constant 
current of 25 mA. Known Mr standards were in- 
cluded (Electrophoresis Calibration Kit, Phar- 
macia, Uppsala). Transfer of separated polypep- 
tides onto a nitrocellulose paper (Transblot 
Transfer Medium, Bio-Rad, Richmond CA) was 
carried out in 25 mM Tris-HCl buffer (pH 8.3) 
containing 192 mM glycine and 20% (v/v) 
methanol, with a commercial blotting apparatus 
(Bio-Rad) as in [l]. For the immunoblotting the 
nitrocellulose strips were soaked in 0.01 M 
phosphate-buffered saline, containing 10% (v/v) 
newborn calf serum and 0.2% (v/v) Triton X-100 
(PBS-NCS-TrXlOO), for 30 min, washed and 
then exposed to 1: 100 diluted human sera in 
PBS-NCS-TrXlOO for 30 min. After washing, 
the nitrocellulose strips were incubated for 30 min 
with peroxidase-conjugated rabbit anti-human IgG 
or IgM, specific for heavy chains (DAKO, 
Copenhagen) diluted 1: 100 in the same buffer as 
above. After washing, the strips were developed 
with 3,3-diaminobenzidintetrahydrochloride 
(DAB; Fluka AG, Buchs), 0.05% DAB made in 
50 mM Tris-HCl (pH 7.6) with 0.03% (v/v) 
HzOZ, was used. All incubations were carried out 
at room temperature. 
3. RESULTS AND DISCUSSION 
The sera S-l, S-2, S-3 and S-4, containing tox- 
oplasma antibodies, revealed patterns of antigenic 
polypeptides closely resembling each other when 
tested by peroxidase-conjugated anti-gamma im- 
munoglobulins (fig. 1). Complex profiles, each 
composed of several separate bands, were observ- 
ed. The range of the estimated &values for these 
IgG reactive polypeptides was 27 000-67 000. 
These results indicate that the IgG antibody 
response is triggered simultaneously by a wide 
spectrum of antigenic components. Interestingly, 
very similar patterns were revealed by IgG tox- 
oplasma antibodies irrespectively whether they 
were from the acute or chronic stage sera. 
Strikingly different patterns presenting only few 
antigens were observed by using peroxidase- 
conjugated anti-mu immunoglobulins (fig. 1). Only 
sera with IgM toxoplasma antibody activity (S-l 
and S-2) showed visible reactions. Both sera 
detected a strong band corresponding to an M, of 
35000. The other serum, S-l, revealed an IgM- 
reactive polypeptide also in the Mr 50000 region. 
Identical patterns were observed by several other 
serum samples taken from individuals with recent 
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Fig. 1. Immunological detection of antigenic polypeptides of Toxoplasma gondii. Toxoplasma proteins were separated 
by SDS-PAGE, followed by electrophoretic blotting onto a nitrocellulose sheet. Antigenic polypeptides were detected 
by toxoplasma ~tibodies from human sera and the reactions were separately visualized by ~roxid~e-conjugate, 
heavy chain-specific anti-human IgG (ah-IgG) and IgM (ah-&M). Five human sera were used; S-l and S-2 contained 
high levels of IgG and IgM toxoplasma antibodies; S-3 and S-4 had only IgG toxoplasma antibodies; S-5 was negative 
for toxoplasma antibodies. In the conjugate control (CC) the diluent buffer was used instead of serum. The positions 
of i&-standards (kDa) are shown on the left. 
toxoplasmosis. This seems to indicate that only 
few antigenic components were responsible for 
eliciting the specific IgM antibody response. This 
has never been reported before. Authors in [3] 
studied surface-labeled toxoplasma tachyzoites by 
immunoprecipitation and detected 4 major an- 
tigenic polypeptides. One of these had an M, of 
35000 and is probably identical with the 
dominating IgM-reactive antigen found here. 
The specificity of the observed patterns of an- 
tigenic components was confirmed by the negative 
control serum (S-5); only one or two faint non- 
specific bands were recognized which could also be 
seen in the conjugated control lane (fig.1) where 
buffer had been used instead of serum. 
Here, we have demonstrated the suitability of 
the immunoblotting technique for the investigation 
of the antigenic structure of T. gondii. A special 
advantage of this method is the possibility to iden- 
tify separately the immunogens stimulating the 
production of antibodies in different im- 
munoglobulin classes. The identification and 
puri~cation of the major antigeni~ components for 
an IgM antibody response could be very valuable 
for diagnostic applications. In earlier studies it has 
been shown that the demonstration of specific IgM 
response by an enzyme immunoassay is a most 
reliable diagnostic marker in acute toxoplasmosis 
[4]. The use of purified antigen would further im- 
prove the specificity and sensitivity of this test. 
Detailed information about the humoral immune 
response in toxoplasmosis could be obtained by in- 
vestigating sequential antigenic profiles as revealed 
by antibodies from serum samples taken at dif- 
ferent stages of infection. 
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